Michael W. Dunne - Jan 1, 2023 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Role: Director
Signature: /s/ Michael W. Dunne
Stock symbol: ITRM
Transactions as of: Jan 1, 2023
Transactions value $: $0
Form type: 4
Date filed: 1/4/2023, 05:00 PM
Previous filing: Dec 28, 2022
Next filing: Jun 5, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ITRM	Ordinary Shares	Options Exercise		+761	+2.14%		36.3K	Jan 1, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ITRM	Restricted Share Units	Options Exercise	$0	-761	-100%	$0.00^*	0	Jan 1, 2023	Ordinary Shares	761	$0.00	Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
F2	On March 25, 2022, the reporting person was granted an award of 11,426 RSUs (the "RSU Grant"), which vested on January 1, 2023.
F3	On August 17, 2022 the Issuer effected a 1 for 15 reverse share split (the "Reverse Share Split"). The number of ordinary shares underlying the RSU Grant have been adjusted to reflect the Reverse Share Split.